Amplifon S.p.A. (LON:0N61)
15.57
+0.04 (0.27%)
At close: Oct 24, 2025
Amplifon Revenue
Amplifon had revenue of 592.70M EUR in the quarter ending June 30, 2025, a decrease of -1.89%. This brings the company's revenue in the last twelve months to 2.41B, up 3.83% year-over-year. In the year 2024, Amplifon had annual revenue of 2.41B with 6.60% growth.
Revenue (ttm)
2.41B EUR
Revenue Growth
+3.83%
P/S Ratio
1.47
Revenue / Employee
160.08K EUR
Employees
15,070
Market Cap
3.05B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.41B | 149.16M | 6.60% |
| Dec 31, 2023 | 2.26B | 140.96M | 6.65% |
| Dec 31, 2022 | 2.12B | 171.05M | 8.78% |
| Dec 31, 2021 | 1.95B | 444.82M | 29.59% |
| Dec 31, 2020 | 1.50B | -228.81M | -13.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |